CD22 and neoplasm: An antibody-drug conjugate that is internalised by CD22+ tumour cells, delivering the conjugated anti-cancer antibiotic, N-acetyl-γ-calicheamicin, which induces double-stranded DNA breaks leading to cancer cell cycle arrest and apoptosis (34).